- Home
- IMTX vs QFIN Comparison
IMTX vs QFIN Comparison
Compare IMTX & QFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMTX | QFIN |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Germany | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IMTX | QFIN |
|---|---|---|
| Price | $8.49 | $6.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $19.00 | ★ $22.20 |
| AVG Volume (30 Days) | 589.4K | ★ 1.6M |
| Earning Date | 05-13-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 12.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.91 | N/A |
| P/E Ratio | ★ N/A | $2.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.06 | $6.75 |
| 52 Week High | $12.41 | $31.08 |
Technical Indicators
Market Signals| Indicator | IMTX | QFIN |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 16.24 |
| Support Level | $8.36 | N/A |
| Resistance Level | $10.51 | $14.03 |
| Average True Range (ATR) | 0.33 | 0.26 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 53.88 | 2.11 |
Price Performance
Historical ComparisonAbout IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About QFIN Qifu Technology Inc.
Qfin Holdings Inc is engaged in matching individual borrowers with credit demand to a diversified pool of financial institutions with credit to supply through a financial technology platform. It has released large-scale financial credit multimodal benchmark, building a critical bridge between credit AI research and real-world applications.